$GROW

U S GLOBAL INVESTORS INC (GROW): Results of Operations and Financial Condition

U S GLOBAL INVESTORS INC (GROW) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_973695.htm EXHIBIT 99.1 ex_973695.htm Exhibit 99.1 Contact: Holly Schoenfeldt Director of Marketing and Public Relations 210.308.1268 hschoenfeldt@usfunds.com For Immediate Release U.S. Global Investors Announces Restatement of EPS for Q3 2026; Reported Financial Str

Original reporting
Published Jun 8, 2026, 3:47 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 9, 2026, 8:46 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$GROW
Neutral
medium confidence
Mentioned
$GROW
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$GROWNeutralLow
01

Why it matters

EPS was overstated due to an omission in weighted-average share calculations; corrected EPS is lower, but consolidated financial statement totals are unchanged.

02

Market read

This is a quality-of-earnings event: per-share figures change, but the company stresses no change to underlying profitability or cash.

03

What to watch

AUM averaged $1.6B and revenue rose QoQ and YoY; traders may re-rate the stock on operating momentum rather than EPS optics.

Relevance 7/10Novelty 6/10Timing: Filed June 8, 2026 (8-K with 10-Q/A restatement)

Background

The company completed an EPS restatement for the three- and nine-month periods ended March 31, 2026, filing an amended Form 10-Q/A.

Company-level read

Ticker impact

$GROWNeutralMedium confidence
Context

U.S. Global Investors filed a 10-Q/A restating Q3 FY2026 EPS after a spreadsheet omission overstated per-share results by $0.02 (basic/diluted).

Expected impact

Likely limited fundamental impact; near-term trading may be driven by investor trust/quality-of-earnings concerns rather than earnings power.

Evidence & confidence

The filing explicitly states only weighted-average share counts and per-share figures changed; underlying financial statement line items and cash position were unchanged.

Market effects

Restatement highlights spreadsheet/control risk for asset managers; may modestly influence sector “quality of earnings” screens.

Primarily affects US small-cap/asset-management sentiment; no stated regional spillover.

No direct global macro or cross-border operational impact mentioned.

Counterpoint

Because net income, revenues, operating income, and cash were unchanged, the restatement may be largely noise for fundamental traders focused on AUM and fee revenue.

Key entities

  • U.S. Global Investors, Inc.

    NASDAQ-listed registered investment adviser that restated Q3 FY2026 EPS after a spreadsheet omission.

  • Lisa Callicotte

    CFO quoted on enhancing controls over spreadsheet calculations.

Related articles

$GROWMedAI 8/10

U.S. Global Investors Announces Intent to Restate EPS for the March 31, 2026, Financial Statements; Underlying Financial Results Unchanged

U.S. Global Investors (NASDAQ: GROW) said it will restate EPS for the three- and nine-month periods ended March 31, 2026, due to a miscalculation of basic and diluted weighted-average shares that omitted a component in a supporting spreadsheet. The company said net income, revenues, operating income, cash, and other line items are unchanged. For the quarter, EPS was overstated by $0.02; corrected basic/diluted EPS is $0.21. For nine months, overstated by $0.01; corrected EPS is reflected in an a

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.